Browse

The RNA-focused drugmaker says Inceptive's tools will help prioritize the best development options as well as speed up the research process.

Inceptive Nucleics and Alnylam's partnership, why Grail's "failed" trial still matters, and other biotech news from The Readout

In this edition of STAT Health Tech: An update on the Utah pilot that uses a chatbot to renew drug prescriptions, AI scribes for patients, and more.